Patents by Inventor Faye A. Rogers

Faye A. Rogers has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11401340
    Abstract: Disclosed herein are methods and agents for the treatment of cancer using p53-independent apoptosis to reduce the number of p53-depleted or p53-mutated cancer cells that have amplified HER2 gene. Also disclosed herein are methods and agents for the treatment of HER2-positive cancer in individuals with Li-Fraumeni Syndrome.
    Type: Grant
    Filed: November 13, 2019
    Date of Patent: August 2, 2022
    Assignee: Yale University
    Inventor: Faye A. Rogers
  • Publication number: 20210222175
    Abstract: Disclosed herein are methods and agents for the treatment of cancer using p53-independent apoptosis to reduce the number of cancer cells that have an amplified HER2 gene, such as p53-depleted or p53-mutated cancer cells that have an amplified HER2 gene. Also disclosed herein are methods and agents for the treatment of HER2-positive cancer in individuals with Li-Fraumeni Syndrome.
    Type: Application
    Filed: January 27, 2021
    Publication date: July 22, 2021
    Applicant: Yale University
    Inventor: Faye A. Rogers
  • Publication number: 20210206874
    Abstract: Disclosed herein are methods and agents for the treatment of cancer using p53-independent apoptosis to reduce the number of p53-depleted or p53-mutated cancer cells that have amplified HER2 gene. Also disclosed herein are methods and agents for the treatment of HER2-positive cancer in individuals with Li-Fraumeni Syndrome.
    Type: Application
    Filed: November 13, 2019
    Publication date: July 8, 2021
    Applicant: Yale University
    Inventor: Faye A. Rogers
  • Publication number: 20200190211
    Abstract: Disclosed herein are methods and agents for the treatment of cancer using p53-independent apoptosis to reduce the number of p53-depleted or p53-mutated cancer cells that have amplified HER2 gene. Also disclosed herein are methods and agents for the treatment of HER2-positive cancer in individuals with Li-Fraumeni Syndrome.
    Type: Application
    Filed: November 13, 2019
    Publication date: June 18, 2020
    Applicant: Yale University
    Inventor: Faye A. Rogers
  • Patent number: 9587238
    Abstract: Described herein are methods of triplex-induced apoptosis, in which multiple triplexes are formed in cells in which gene amplification has occurred (cells comprising/characterized by at least one amplified gene), referred to as target cells, and apoptosis is induced in the target cells.
    Type: Grant
    Filed: July 18, 2014
    Date of Patent: March 7, 2017
    Assignee: Yale University
    Inventor: Faye A. Rogers